PMEL and melanoma: Several studies established Gp-100 as a common immunogenic melanoma antigen; Kawakami et al. described that mTILs recognized short peptides presented by HLA-A2 restricted class I MHC molecules, such as YLEPGPVTA, an epitope of Gp-100 [13].